|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2007-2-19
|
|
pubmed:abstractText |
To evaluate the antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA), a vascular disrupting agent currently under phase II clinical trials in combination with cancer chemotherapy, in rats bearing chemically induced primary mammary tumours.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0344-5704
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
661-9
|
|
pubmed:meshHeading |
pubmed-meshheading:16944150-Animals,
pubmed-meshheading:16944150-Antineoplastic Agents,
pubmed-meshheading:16944150-Apoptosis,
pubmed-meshheading:16944150-Carcinogens,
pubmed-meshheading:16944150-Cytokines,
pubmed-meshheading:16944150-Female,
pubmed-meshheading:16944150-Immunoassay,
pubmed-meshheading:16944150-In Situ Nick-End Labeling,
pubmed-meshheading:16944150-Mammary Neoplasms, Experimental,
pubmed-meshheading:16944150-Methylnitrosourea,
pubmed-meshheading:16944150-Rats,
pubmed-meshheading:16944150-Xanthones
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
|
|
pubmed:affiliation |
Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Private bag 92019, Auckland, New Zealand.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
